eGFP/Firefly Luciferase MIA PaCa-2 Cell Line

Catalog #
78766
$3,250 *
Size: 2 vials
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant MIA PaCa-2 cells expressing firefly luciferase and enhanced GFP (eGFP) driven by an EF1a promoter, generated by transduction with Firefly Luciferase-eGFP lentivirus (BPS Bioscience #78741).

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Product Info
Storage and Usage
Citations
Host Cell Line
MIA PaCa-2, human pancreatic carcinoma cell line, adherent.
Supplied As
Each vial contains 2 x 106 cells in 1 ml of Cell Freezing Medium (BPS Bioscience #79796)
Materials Required But Not Supplied
Name Ordering Information
Thaw Medium 17 BPS Bioscience #78767
Growth Medium 17A BPS Bioscience #78768
Mycoplasma Testing

The cell line has been screened to confirm the absence of Mycoplasma species.

Background

MIA PaCa-2 is a human epithelial cell line derived from the pancreatic cancer tissue of a 65-year-old male. It is commonly used as a tumor model in pancreatic cancer research and therapy development. The genotyping of MIA PaCa-2 confirmed the presence of a homozygous missense mutation (G12C) in KRAS (K-Ras), a homozygous deletion encompassing exons 1, 2 and 3 of the CDKN2A/p16INK4A (cyclin-dependent kinase inhibitor 2A) gene and a homozygous missense mutation (R248W) in exon 7 of TP53 (tumor protein 53, or p53).